ALB and neoplasm: HuNbTROP2-HSA-MMAE at a dose of 0.2 mg/kg already showed significant tumor growth inhibition, while HuNbTROP2-HSA-MMAE at 5 mg/kg exhibited even stronger antitumor efficacy, resulting in complete clearance of pre-existing tumors.